Mips Logo

Mips

Licenses patented helmet technology to reduce rotational impact injuries in sports and construction.

MIPS | ST

Overview

Corporate Details

ISIN(s):
SE0009216278 (+4 more)
LEI:
549300LZSA4S0L54VQ25
Country:
Sweden
Address:
Kemistvägen 1B, 183 79 TÄBY
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Mips is a developer of helmet-based safety technology focused on reducing head injuries. Its core product is the Mips® Safety System (Multi-Directional Impact Protection System), a patented Brain Protection System (BPS). Born from scientific research by a brain surgeon and a biomechanics scientist, the system incorporates a low-friction layer inside helmets. This layer is designed to move slightly upon an angled impact, helping to redirect harmful rotational motion away from the head and potentially reducing the risk of certain brain injuries. Mips licenses its technology to numerous helmet manufacturers for use in products across a wide range of markets, including cycling, snow sports, motorcycling, equestrian, and construction.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-22 07:30
Quarterly Report
Swedish 2.2 MB
2025-10-22 07:30
Quarterly Report
English 2.2 MB
2025-07-16 07:30
Earnings Release
Swedish 1.9 MB
2025-07-16 07:30
Earnings Release
English 1.9 MB
2025-05-07 11:45
AGM Information
Kommuniké från årsstämman i Mips AB (publ) den 7 maj 2025
Swedish 36.0 KB
2025-05-07 11:45
AGM Information
Press release from the Annual General Meeting in Mips AB (publ) on 7 May 2025
English 33.4 KB
2025-04-24 07:30
Quarterly Report
Swedish 1.2 MB
2025-04-24 07:30
Quarterly Report
English 1.2 MB
2025-03-20 17:20
Annual Report (ESEF)
Swedish 2.5 MB
2025-02-05 18:10
Earnings Release
Mips updates long-term financial target
English 39.4 KB
2025-02-05 18:10
Report Publication Announcement
Mips uppdaterar långsiktigt finansiellt mål
Swedish 39.3 KB
2025-02-05 18:10
Earnings Release
Swedish 3.0 MB
2025-02-05 18:10
Annual Report
English 3.0 MB
2024-10-24 07:30
Quarterly Report
Swedish 1.3 MB
2024-10-24 07:30
Interim / Quarterly Report
English 1.4 MB

Automate Your Workflow. Get a real-time feed of all Mips filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mips

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mips via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-10-25 Thomas Bräutigam Other Sell 4,500 2,430,000.00 SEK
2023-09-14 John Fredrik Kjellberg Other Sell 10,300 3,705,837.00 SEK
2023-03-03 Maria Hedengren Other Buy 200 98,254.00 SEK
2022-10-18 Thomas Bräutigam Other Buy 2,000 609,594.40 SEK
2022-10-17 Thomas Bräutigam Other Buy 3,000 907,927.80 SEK
2022-05-06 Thomas Bräutigam Other Buy 1,000 580,600.00 SEK
2022-05-05 Thomas Bräutigam Other Buy 2,000 1,253,200.00 SEK
2022-03-07 Jonas Rahmn Other Buy 107 75,301.25 SEK
2022-03-07 Jonas Rahmn Other Buy 94 66,317.00 SEK
2022-03-07 Jonas Rahmn Other Buy 90 63,495.00 SEK

Peer Companies

Gubra A/S Logo
CRO & biotech accelerating peptide drug discovery for metabolic and fibrotic diseases.
Denmark
GUBRA
HALOZYME THERAPEUTICS, INC. Logo
Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.
United States of America
HALO
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan
4593
HeartSciences Inc. Logo
AI-powered ECG technology for early detection of heart disease and advanced diagnostics.
United States of America
HSCS
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan
219A
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland
HRTIS
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland
HPE
HLB bioStep Co.,Ltd. Logo
South Korea
278650
HLB PANAGENE Co., LTD. Logo
A global leader in PNA technology for cancer diagnostics and precision medicine.
South Korea
046210
HLB SCIENCE Inc. Logo
Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.
South Korea
343090

Talk to a Data Expert

Have a question? We'll get back to you promptly.